So excited to share our new paper @NatureCancer on PSMA regulation in AR-positive and AR-negative prostate cancer. Congratulations to lead author @mkbakht @DanaFarber We are grateful for many wonderful collaborators @DanaFarber_GU @PCF_Science
nature.com/articles/s4301…
Misha Beltran
888 posts
Boston, MA
Joined September 2013
- Precision medicine for advanced prostate cancer patients is moving closer to reality. Here is our recent review @NatRevUrol @ShengyuKu @marty_gleave @PCF_Science nature.com/articles/s4158…
- Excited about the potential of cfDNA genomics & methylation to understand prostate cancer resistance and identify NEPC. Our new study @jclinicalinvest with @FrancescaBZNY and many great collaborators @aromanel @DrScottTagawa and many more @PCF_Science jci.org/articles/view/…
- In memory of Dr. Felix Feng. Thank you @EUplatinum for honoring our beloved colleague and friend, gone too soon. We miss you Felix @MaryFengMD @nlinmd @PCF_Science sciencedirect.com/science/articl…
- Great to work together with many colleagues as we outline current challenges in treating metastatic prostate cancer and strategies to improve precision medicine. Here is our new Perspective @NatureCancer @quimmateo @NCIBillDahut @PCF_Science nature.com/articles/s4301…
- Check out our new review in @NatRevUrol on biologic determinants of PSMA expression, regulation, and heterogeneity in prostate cancer led by @mkbakht @DanaFarber_GU @PCF_Science Link to paper: rdcu.be/dM7GF nature.com/articles/s4158…
- Proud to share our lab's new paper led by @YasutakaYamada now out in @ScienceTM. Here we study the role of targeting DNA methylation in NEPC and RB1-deficient CRPC and co-targeting with B7-H3. @DanaFarber_GU #BeltranLab
- Happy for some good news during this time. So grateful for @theNCI @NIHfunding to expand our research and proud of our great team @danafarber @harvardmed #WomenInScience #TheBeltranLab #BestTeamEverAge-restricted adult content. This content might not be appropriate for people under 18 years old. To view this media, you’ll need to log in to X. Learn more
- Noninvasive detection of NEPC by targeted cfDNA methylation @CD_AACR co-led by @FrancescaBZNY and her lab @UniTrento. Congrats to first author @GMFranceschini and thank you to many amazing collaborators @PCF_Science @DanaFarber_GU #NEMO aacrjournals.org/cancerdiscover…
- It was such an honor giving the Felix Feng Lecture at the #pcfretreat24 on Friendship and Science. Thank you Felix for all your contributions to the field and for being an amazing friend. The love for you in the room was just palpable @PCF_ScienceThis Post is from a suspended account. Learn more
- Congratulations @Bajji! Our new paper @NatureComms highlights the context specific role of EZH2 in prostate cancer. Thank you to many collaborators @maverybrown @RickmanLab and funding support @PCFnews @df_hcc @theNCI #SPORE rdcu.be/dQo0P @DanaFarber #BeltranLab
- Thank you to the NCI for an exciting workshop on lineage plasticity in prostate cancer. Here is summary manuscript @CCR_AACR dedicated to Dr. Andrew Hruszkewycz @NCIBillDahut clincancerres.aacrjournals.org/content/early/…
- Proud to share our paper @jclinicalinvest led by @ShengyuKu @DanaFarber with #GoodrichLab @RoswellPark: Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer @PCF_Science jci.org/articles/view/…
- Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so many brilliant women in the field #WomenInScience #WomenAndGirlsInScience🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: go.nature.com/3pTxxwF #11F #WomenInScience #WomenAndGirlsInScience @UN_Women














